[1]
N. Shokatpour, S. Sali, A. Khahanipour, S. Abolghasemi, and M. Shabani, “Daclatasvir/Sofosbuvir versus Ledipasvir/Sofosbuvir in Patients with Hepatitis C Virus Infection Genotypes 1 and 3”, Novel Biomed, vol. 8, no. 4, pp. 171–181, Jun. 2020.